|

CYB003 Clinical Trials

2 actively recruiting trials across 2 locations

▼ -1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Ohio State University1
  • Cybin IRL Limited1

Indications

  • Depression2
  • Depression Disorder1
  • Major Depressive Disorder (MDD)1
  • Major Depressive Disorder1
  • Depression Disorders1

Birmingham, Alabama1 trial

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

UAB Psychiatry and Behavioral Neurology

Phase 3

Columbus, Ohio1 trial

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

The Ohio State University Department of Psychiatry

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.